RAD51 and cancer: Moreover, the treatment of cancer cells with chemotherapeutic drug (cisplatin) led to activation of mechanisms which disrupt immune surveillance and maintenance of genetic material, whereas addition of RAD51 inhibitor prevented activation of such mechanisms.